SCHEMBL312293

SCHEMBL312293

CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCSCC3)c(F)c21

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.67
HSD17B10 Q99714 7/20 0.67
HPGD P15428 7/20 0.67
ALDH1A1 P00352 6/20 0.67
PMP22 Q01453 1/20 0.66
DRD3 P35462 1/20 0.52
ADRA2B P18089 1/20 0.52
MAPK1 P28482 1/20 0.52
LMNA P02545 3/20 0.51
BRD4 O60885 1/20 0.51
TSHR P16473 1/20 0.51
HTT P42858 1/20 0.51
CYP2J2 P51589 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
CYP2C9 P11712 1/20 0.49
ATP6V1B2 P21281 1/20 0.49
TBXA2R P21731 1/20 0.49
EDNRA P25101 1/20 0.49
TARBP2 Q15633 1/20 0.49
MEN1 O00255 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11091134 0.94 KDM4E (0.65) KDM4EHSD17B10HPGDALDH1A1PMP22
SCHEMBL11185030 0.90 KDM4E (0.71) KDM4EHSD17B10HPGDALDH1A1PMP22
SCHEMBL312380 0.88 KDM4E (0.84) KDM4EHSD17B10HPGDALDH1A1PMP22
SCHEMBL312663 0.88 KDM4E (0.70) KDM4EHSD17B10HPGDALDH1A1PMP22
SCHEMBL10739914 0.88 KDM4E (0.70) KDM4EHSD17B10HPGDALDH1A1PMP22
SCHEMBL312379 0.87 KDM4E (0.76) KDM4EHSD17B10HPGDALDH1A1PMP22
SCHEMBL311638 0.87 KDM4E (0.67) KDM4EHSD17B10HPGDALDH1A1PMP22
Hydrochloric Acid SCHEMBL10738181 0.87 KDM4E (0.69) KDM4EHSD17B10HPGDALDH1A1PMP22
SCHEMBL312122 0.86 KDM4E (0.72) KDM4EHSD17B10HPGDALDH1A1PMP22
SCHEMBL312030 0.86 KDM4E (0.69) KDM4EHSD17B10HPGDALDH1A1PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4473568-A ANTIBACTERIAL AGENTS WARNER LAMBERT COMPANY (US) 1984-09-25 US claimed
US-8093381-B2 Method of synthesis of fluoroquinolones BIOCODEX (FR) 2012-01-10 US disclosed
US-20090054643-A1 NOVEL METHOD OF SYNTHESIS OF FLUOROQUINOLONES BIOCODEX (FR) 2009-02-26 US disclosed
US-4473568-A ANTIBACTERIAL AGENTS WARNER LAMBERT COMPANY (US) 1984-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054643-A1 NOVEL METHOD OF SYNTHESIS OF FLUOROQUINOLONES NQO2, Q6ZSR9, QARS1 KDM4E 2435/4885HSD17B10 1768/4885HPGD 1739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.